OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A combination of virtual screening, molecular dynamics simulation, MM/PBSA, ADMET, and DFT calculations to identify a potential DPP4 inhibitor
Fatemeh Zare, Elaheh Ataollahi, Pegah Mardaneh, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

6-Bromo quinazoline derivatives as cytotoxic agents: design, synthesis, molecular docking and MD simulation
Leila Emami, Maryam Hassani, Pegah Mardaneh, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 3

Perspectives on current approaches to virtual screening in drug discovery
Ingo Muegge, Jörg Bentzien, Ge Yunhui
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 10, pp. 1173-1183
Closed Access | Times Cited: 2

Insights into DES Stability and Reactivity with Carboxylic Acids: A Computational Approach
Sandeep Yadav, Ayushi Prajapat, Mohd. Aslam, et al.
Journal of Computational Biophysics and Chemistry (2024) Vol. 23, Iss. 10, pp. 1303-1323
Closed Access | Times Cited: 1

Exploring cutting-edge approaches in diabetes care: from nanotechnology to personalized therapeutics
Gihan F. Asaad, Ahmed S. Doghish, Ahmed A. Rashad, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Open Access | Times Cited: 1

Structure-based screening of FDA-approved drugs and molecular dynamics simulation to identify potential leukocyte antigen related protein (PTP-LAR) inhibitors
Shan Du, Xinxin Zhang, Xiang Gao, et al.
Computational Biology and Chemistry (2024) Vol. 113, pp. 108264-108264
Closed Access

Ashwagandharishta compounds possess affinity interactions against diabetes-linked liver cancer: Implications from network pharmacology, molecular docking and dynamics simulations
Annadurai Vinothkanna, Ligang Chen, R. Prathiviraj, et al.
South African Journal of Botany (2024) Vol. 177, pp. 26-49
Closed Access

Therapeutic potential inhibitor for dipeptidyl peptidase IV in diabetic type 2: in silico approaches
Miah Roney, Amit Dubey, Md. Nazim Uddin, et al.
3 Biotech (2024) Vol. 15, Iss. 1
Closed Access

Computational design of potent dimeric phenylthiazole NS5A inhibitors for hepatitis C virus
Wissal Liman, Mehdi Oubahmane, Nouhaila Ait Lahcen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Exploration of Rutin Derivatives as Potential Inhibitors of Prostate Cancer Signaling Pathways: A Comprehensive In-Silico Study
Shristi Modanwal, Ashutosh Mishra, Nidhi Mishra
Biochemical and Biophysical Research Communications (2024) Vol. 746, pp. 151279-151279
Closed Access

Page 1

Scroll to top